Clinical trials for Cancer in United States

Establishing a Tumor Registry of Patients With Mesonephric-like Adenocarcinoma (MLA)

Study ID: NCT06377527

Sponsor

M.D. Anderson Cancer Center

Transoral Surgical Resection Followed by De-escalated Adjuvant IMRT in Resectable p16+ Locally Advanced Oropharynx Cancer

Study ID: NCT05388773

Sponsor

Heath Skinner

Neurosurgical Neuronavigation Using Resting State MRI and Machine Learning

Study ID: NCT05864976

Sponsor

Washington University School of Medicine

Acalabrutinib, Obinutuzumab, and Glofitamab for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma

Study ID: NCT06054776

Sponsor

City of Hope Medical Center

A Study of Chemoimmunotherapy for the Treatment of Men With Neuroendocrine or Aggressive Variant Metastatic Prostate Cancer

Study ID: NCT04709276

Sponsor

Andrew J. Armstrong, MD

ASk Questions in GYnecologic Oncology (ASQ-GYO)

Study ID: NCT06339827

Sponsor

Ira Winer

Immune Cell Therapy (CAR-T) for the Treatment of Patients With HIV and B-Cell Non-Hodgkin Lymphoma

Study ID: NCT05077527

Sponsor

AIDS Malignancy Consortium

Study to Allow Patients Previously Participating in a Novartis Sponsored Trial to Continue Receiving Capmatinib Treatment as Single Agent or in Combination With Other Treatments or the Combination Treatment Alone

Study ID: NCT03040973

Sponsor

Novartis Pharmaceuticals

A Study of MGD024 in Patients With Relapsed or Refractory Hematologic Malignancies

Study ID: NCT05362773

Sponsor

Macrogenics

Brentuximab Vedotin and Nivolumab for the Treatment of Relapsed/Refractory Classic Hodgkin Lymphoma Previously Treated with Brentuximab Vedotin or Checkpoint Inhibitors

Study ID: NCT05039073

Sponsor

Emory University